King Faisal Specialist Hospital & Research Centre (KFSHRC) has concluded its participation in the prestigious 2024 NYC C3 Summit Davos of Healthcare, leaving an indelible mark on the global healthcare landscape. As a C3 Strategic Partner and Scientific Committee Chair, KFSHRC played a pivotal role in shaping the future of healthcare, tackling crucial challenges and driving meaningful discussions.
The summit saw KFSHRC leaders spearheading key presentations on cutting-edge topics such as biotechnology, artificial intelligence (AI), robotics, and precision medicine. The spotlight shone brightly on KFSHRC’s Deputy Chief Executive Officer (DCEO), Dr. Björn Zoéga, who received the esteemed 2024 C3 Global Innovative Healthcare & Impact Transformation Award. This recognition underscores KFSHRC’s unwavering commitment to enhancing patient care through innovative solutions, increasing accessibility, and reducing healthcare costs while embracing sustainability and social responsibility.
Throughout the summit, KFSHRC’s leadership, including Dr. Zoéga, Dr. Edward Cupler, Executive Director of Research and Innovation, Dr. Feras Khaliel, Head of Cardiac Surgery and Director of the Robotics and Minimally Invasive Surgery Program, and Dr. Salah Baz, Head of Genomic Medicine, led engaging sessions on advanced medical technologies. Dr. Cupler shared valuable insights into KFSHRC’s journey to position Saudi Arabia as a global Biotech powerhouse, while Dr. Khaliel explored the transformative potential of robotics in surgery. Dr. Baz’s session on whole genome sequencing (WGS) highlighted its potential in diagnosing rare diseases and advancing personalized care.
Looking ahead, KFSHRC remains dedicated to forging global partnerships and fulfilling its mission of delivering accessible, patient-centered, and technology-driven healthcare solutions that leave a lasting impact on patients worldwide.
KFSHRC’s remarkable achievements have been recognized globally. The institution was ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year. It was also crowned as the most valuable healthcare brand in the Kingdom and the Middle East according to the 2024 Brand Finance rankings. Furthermore, Newsweek magazine acknowledged KFSHRC as one of the world’s best 250 hospitals in the same year. These accolades solidify KFSHRC’s reputation as a beacon of excellence in healthcare, setting a high standard for global healthcare innovation and transformation.
